In the course of the application of “Regulation (EU) 2017/746” (IVDR) on May 26, 2022, the AltoStar® Parvovirus B19 PCR Kit 1.5 has received a new product number and Global Trade Item Number (GTIN). The new product number reflects the desired change in regulatory status. All other product characteristics as well as the product performance remain unchanged. The kit is chemically identical to its already existing counterpart and contains the same kit components.
Products not FDA cleared or approved. Kits not available in all countries.
The AltoStar® Parvovirus B19 PCR Kit 1.5 is an in vitro diagnostic test, based on real-time PCR technology, for the detection and quantification of parvovirus B19 specific DNA in human plasma. It is intended to be used as an aid for diagnosis of parvovirus B19 infection and for monitoring of the parvovirus B19 load in individuals with parvovirus B19 infection.
Key features
- Detection and quantification of human parvovirus B19 specific DNA
- CE-IVD marked in vitro diagnostic test
- Analytical sensitivity reported in IU/ml
Limit of detection (LoD)
| LoD plasma | 121 IU/ml |
Sample types
The following sample types are validated for use with the AltoStar® Parvovirus B19 PCR Kit 1.5:
- Human EDTA plasma
- Human citrate plasma
Other workflows
The AltoStar® Parvovirus B19 PCR Kit 1.5 can be used with compatible workflows (manual or automated). Real-time PCR instruments that have been validated for use with the AltoStar® Parvovirus B19 PCR Kit 1.5 are:
- CFX96™ Deep Well Dx System (Bio-Rad)
- CFX96™ Dx System (Bio-Rad)
- ABI Prism® 7500 SDS (Applied Biosystems)
- LightCycler® 480 Instrument II (Roche)
- QuantStudio™ 5 Real-Time PCR System (Applied Biosystems)
- Rotor-Gene® Q5/6 plex Platform (QIAGEN)
The AltoStar® Parvovirus B19 PCR Kit 1.5 can be used with nucleic acid extraction systems other than the AltoStar® AM16. Alternative procedures used for nucleic acid extraction have to be validated by the user.
